How have CPIX shares performed in 2023?

Cumberland Pharmaceuticals' stock was trading at $2.25 at the beginning of the year. Since then, CPIX stock has decreased by 21.3% and is now trading at $1.77. View the best growth stocks for 2023 here .

Are investors shorting Cumberland Pharmaceuticals?

Cumberland Pharmaceuticals saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 18,600 shares, a drop of 25.6% from the October 31st total of 25,000 shares. Based on an average daily trading volume, of 18,100 shares, the short-interest ratio is presently 1.0 days. Currently, 0.2% of the company's stock are short sold. View Cumberland Pharmaceuticals' Short Interest .

When is Cumberland Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 5th 2024. View our CPIX earnings forecast .

How were Cumberland Pharmaceuticals' earnings last quarter?

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced its quarterly earnings results on Tuesday, November, 7th. The specialty pharmaceutical company reported $0.02 earnings per share for the quarter. The specialty pharmaceutical company had revenue of $10.09 million for the quarter. Cumberland Pharmaceuticals had a positive trailing twelve-month return on equity of 8.68% and a negative net margin of 6.17%.

What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO?

9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com . A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Cumberland Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC) , VIVUS (VVUS) , CymaBay Therapeutics (CBAY) , Sorrento Therapeutics (SRNE) , SCYNEXIS (SCYX) , VBI Vaccines (VBIV) , Akero Therapeutics (AKRO) , Cerecor (CERC) , Xeris Biopharma (XERS) .

Who are Cumberland Pharmaceuticals' major shareholders?

Cumberland Pharmaceuticals' stock is owned by many different institutional and retail investors. Top institutional investors include Bank of New York Mellon Corp (0.52%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include A J Kazimi , A J Kazimi , Caroline Young, James Jones, Joseph C Galante , Kenneth Krogulski , Martin E Cearnal, Martin E Cearnal and William Sumas . View institutional ownership trends .

How do I buy shares of Cumberland Pharmaceuticals?

Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Cumberland Pharmaceuticals Stock Price, News & Analysis (NASDAQ:CPIX)

$1.77

+0.10 (+5.99%)

(As of 11/28/2023 ET)

Compare

Today's Range: $1.65
▼
$1.77
50-Day Range: $1.60
▼
$2.30
52-Week Range: $1.43
▼
$2.91

Volume: 4,824 shs
Average Volume: 20,459 shs
Market Capitalization: $25.24 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Cumberland Pharmaceuticals Stock (NASDAQ:CPIX)

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

CPIX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CPIX Stock News Headlines

November 28, 2023 | msn.com

Man dies after Cumberland County shooting late Monday

November 27, 2023 | msn.com

Group to meet to set demolition date for old U.S. 60 Cumberland River ‘Smithland’ Bridge

November 28, 2023 | RYSE INC. (Ad)

Secure your stake in the Smart Home industry.

Last chance to invest in RYSE – the shade automation technology launching in over 100 Best Buy stores this month.

November 27, 2023 | news.yahoo.com

Cumberland man arrested in handgun assault

November 27, 2023 | msn.com

Most recent median home sales in Cumberland County down slightly

November 27, 2023 | nj.com

See all homes sold in Cumberland County, Nov. 20 to Nov. 26

November 26, 2023 | msn.com

Cumberland Council unveils new gum-busting machines

November 24, 2023 | msn.com

Multiple injuries reported following rollover crash on I-81 in Cumberland County

November 28, 2023 | RYSE INC. (Ad)

Secure your stake in the Smart Home industry.

Last chance to invest in RYSE – the shade automation technology launching in over 100 Best Buy stores this month.

November 24, 2023 | msn.com

Suspect arrested after hours-long standoff in Cumberland County

November 24, 2023 | msn.com

Man arrested for assault after Cumberland Co. police respond for six hours

November 24, 2023 | americanbankingnews.com

StockNews.com Begins Coverage on Cumberland Pharmaceuticals (NASDAQ:CPIX)

November 23, 2023 | msn.com

Cumberland Council: Austerity blamed for overspend

November 23, 2023 | msn.com

Number of electric car charging points rose by a fifth in Cumberland

November 23, 2023 | yahoo.com

Cumberland: 'State-of-the-art' gum-removal machine unveiled

November 23, 2023 | msn.com

Cumberland councillors approve own 20% payrise

November 23, 2023 | sports.yahoo.com

Cumberland's Kibiwott takes 46th at NAIA nationals

November 22, 2023 | msn.com

Bobcat spotted in Cumberland

November 22, 2023 | msn.com

Cumberland County English teacher handcuffed outside class at end of school fundraiser

November 22, 2023 | msn.com

Cumberland hosts signing day celebration for 7 student-athletes

November 22, 2023 | msn.com

Cumberland County OKs proposal to build new parking deck in downtown Fayetteville

November 22, 2023 | msn.com

Police: Suspect steals Cumberland County resident's identity to make more than $8,000 in fraudulent cash withdrawals

November 21, 2023 | msn.com

24 is more than just a number for Cumberland High School football

November 21, 2023 | msn.com

Cumberland County man gets 20-year minimum prison term for causing baby’s death

November 21, 2023 | msn.com

Marvin Connelly of Cumberland County Schools named top superintendent in North Carolina

November 21, 2023 | msn.com

Cumberland restaurant handed new five-star food hygiene rating

November 21, 2023 | news.yahoo.com

Cumberland County prepares for white flag shelter nights, but some say there aren't enough

See More Headlines

Receive CPIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/07/2023
Today: 11/28/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 3/05/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: Pharmaceuticals
Sector: Medical
Current Symbol: NASDAQ:CPIX
CUSIP: 23077010
CIK: 1087294
Web: www.cumberlandpharma.com
Phone: (615) 255-0068
Fax: 615-255-0094
Employees: 85
Year Founded: 1999

Profitability

EPS (Most Recent Fiscal Year): ($0.17)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-5,570,000.00
Net Margins: -6.17%
Pretax Margin: -6.15%
Return on Equity: 8.68%
Return on Assets: 3.49%

Debt

Debt-to-Equity Ratio: 0.36
Current Ratio: 1.53
Quick Ratio: 1.21

Sales & Book Value

Annual Sales: $42.01 million
Price / Sales: 0.58
Cash Flow: $0.47 per share
Price / Cash Flow: 3.65
Book Value: $2.45 per share
Price / Book: 0.70

Miscellaneous

Outstanding Shares: 14,260,000
Free Float: 8,259,000
Market Cap: $24.38 million
Optionable: Optionable
Beta: 0.22

Social Links

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. A. J. Kazimi MBA (Age 65)
Founder, Chairman, President & CEO
Comp: $897.5k
Mr. John Michael Hamm (Age 67)
Chief Financial Officer
Comp: $231.38k
Mr. James Lowrance Herman (Age 68)
Executive VP of National Accounts & Chief Compliance Officer
Comp: $352.65k
Ms. Jean W. Marstiller (Age 73)
Senior VP of Administrative Services & Corporate Secretary
Comp: $282.17k
Mr. Chris T. Bitterman (Age 58)
Vice President of Sales & Marketing
Mr. Adam S. Mostafa (Age 43)
Managing Director
Mr. Todd M. Anthony (Age 62)
Vice President of Organizational Development
Ms. Erin Smith Gull
Senior Corporate Relations Associate

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CPIX Stock Analysis - Frequently Asked Questions

How have CPIX shares performed in 2023?: Cumberland Pharmaceuticals' stock was trading at $2.25 at the beginning of the year. Since then, CPIX stock has decreased by 21.3% and is now trading at $1.77.
View the best growth stocks for 2023 here.
Are investors shorting Cumberland Pharmaceuticals?: Cumberland Pharmaceuticals saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 18,600 shares, a drop of 25.6% from the October 31st total of 25,000 shares. Based on an average daily trading volume, of 18,100 shares, the short-interest ratio is presently 1.0 days. Currently, 0.2% of the company's stock are short sold.
View Cumberland Pharmaceuticals' Short Interest.
When is Cumberland Pharmaceuticals' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 5th 2024.
View our CPIX earnings forecast.
How were Cumberland Pharmaceuticals' earnings last quarter?: Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) announced its quarterly earnings results on Tuesday, November, 7th. The specialty pharmaceutical company reported $0.02 earnings per share for the quarter. The specialty pharmaceutical company had revenue of $10.09 million for the quarter. Cumberland Pharmaceuticals had a positive trailing twelve-month return on equity of 8.68% and a negative net margin of 6.17%.

What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO?: 9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Cumberland Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS).
Who are Cumberland Pharmaceuticals' major shareholders?: Cumberland Pharmaceuticals' stock is owned by many different institutional and retail investors. Top institutional investors include Bank of New York Mellon Corp (0.52%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include A J Kazimi, A J Kazimi, Caroline Young, James Jones, Joseph C Galante, Kenneth Krogulski, Martin E Cearnal, Martin E Cearnal and William Sumas.
View institutional ownership trends.
How do I buy shares of Cumberland Pharmaceuticals?: Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:CPIX) was last updated on 11/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cumberland Pharmaceuticals Stock Price, News & Analysis (NASDAQ:CPIX)

About Cumberland Pharmaceuticals Stock (NASDAQ:CPIX)

CPIX Stock Price History

CPIX Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

CPIX Stock Analysis - Frequently Asked Questions

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info